A bill for an act imposing a sales tax on the sales price of items containing traceable amounts of piper methysticum.
Summary
House File 141 would amend Iowa’s sales tax law to specifically exclude piper methysticum from the definition of food and food ingredients, and to define that term as any item containing traceable amounts of piper methysticum. In practical effect, the bill would impose sales tax on the sale of products containing piper methysticum, which is commonly known as kava, even when those products might otherwise be treated as food or dietary supplements under existing tax rules.
The bill makes two related changes to the state tax code. First, it adds piper methysticum to the list of items that are not considered food or food ingredients for sales tax purposes. Second, it amends the dietary supplement definition so that products containing piper methysticum are excluded from that category as well. The result is that kava-containing products would be taxed rather than receiving the sales tax treatment available to food or dietary supplements.
Impact
HF 141 would directly affect Iowa Code section 423.3, subsection 57, which governs sales tax exemptions for food, food ingredients, and related categories. By carving out piper methysticum from both food and dietary supplement definitions, the bill would broaden the taxable base for retailers selling kava products and clarify that these items are subject to sales tax. The practical impact would fall on sellers, distributors, and consumers of kava-containing products, while leaving the broader food and supplement exemptions intact for other items.
Sentiment
The available legislative context suggests generally favorable treatment of the bill, as the subcommittee recommended passage and there is no recorded opposition in the provided materials. Because there are no committee transcripts or floor votes included, there is little evidence of broader debate. The bill appears to have moved forward without documented controversy in the materials provided.
Contention
The main point of contention, based on the bill text itself, is the policy choice to single out piper methysticum for different tax treatment than other food or dietary supplement products. That could raise questions about whether kava should be treated like a supplement, a food item, or a separately taxable product. However, no specific objections, amendments, or opposing arguments are included in the provided record, so any contention is only inferable from the statutory carve-out rather than documented debate.